Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will report first quarter 2026 financial results and operational highlights on May 6, 2026 at 8:30 a.m. ET. A live webcast and conference call will be available, with replay access from 11:30 a.m. ET May 6 through 11:59 p.m. ET May 13, 2026.
Participants may register for automated call-back or dial in directly; the webcast will remain on the investor site through June 6, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – NVAX
In the Apr 30 session, NVAX declined 0.56%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 19 | Earnings date notice | Neutral | +6.2% | Scheduled Q4 and full-year 2025 earnings call with access details for investors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited same-tag history: the prior earnings-date announcement saw a 6.16% positive move, suggesting scheduling updates have previously coincided with a constructive bias.
Over recent months, Novavax has combined capital markets communication with strategic and financial updates. An earlier Feb 19, 2026 earnings-date notice preceded Q4 and full-year 2025 results and coincided with a 6.16% gain. Subsequent Q4 2025 earnings on Feb 26, 2026 showed revenue of $147M for the quarter and $1.123B for 2025, plus a $330M credit facility, and the stock rose 17.42%. The current announcement similarly sets expectations ahead of detailed Q1 2026 results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference call details: | |
Date: | May 6, 2026 |
Time: | 8:30 a.m. ET |
URL to register phone: | |
Dial-in number: | (888) 880-3330 ( |
(+1) (646) 357-8766 (International) | |
Webcast: |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.
Replay details: | |
Date: | Available starting at 11:30 a.m. ET, May 6, 2026, until 11:59 p.m. ET, May 13, 2026 |
Dial-in number: | (800) 770-2030 ( |
(+1) (609) 800-9909 (International) | |
Passcode: | 1309751# |
Webcast: | ir.novavax.com/events, until June 6, 2026 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-first-quarter-2026-financial-results-on-may-6-2026-302757475.html
SOURCE Novavax, Inc.